The second Cancer genomics congress
31 July 2024
111 visit
The formation of a cancer prevention and treatment startup ecosystem
The first meeting of the strategic council of the 2nd Cancer genomics congress was held concentrating on the country startup ecosystem creation, and the CEO of Amper Innovation Factory was introduced as the commercialization secretary of this congress by the head of the knowledge-based health economy development headquarters.
According to Amper public relations report, in this meeting, Mostafa Ghanei, the president of the International Cancer genomics congress, stated: Considering the experience gained in the first congress and with the effective cooperation of scientific and academic centers in technology, commercialization and social responsibility, will be held more serious in the second congress.
The secretary of the knowledge-based economy development of the science and technology announced the importance of forming the cancer prevention and treatment economy and designing an economic model in this field: we emphasize on the cooperation of scientific associations as the most crucial organizations May their role would be more prominent for the goals considered for cancer treatment, he said .
Ghanei also pointed out that cancer, a serious challenge in the world's health, has become one of the leading causes of death: therefore, the International Cancer genomics congress will a good opportunity for the society to perceive more about the challenges ahead. It will prevent cancer and problems related to its treatment.
The head of the development staff of the health economist Salamat added: For this purpose, we created the commercialization committee of the Congress along with other previous departments and tried to have a more serious entry.
The Head of the Health Knowledge-based Economy Development Department added: For this purpose, we created the commercialization committee of the Congress along with other previous departments and tried to have a more serious entry.
Therefore, we invited Parviz Karami, the CEO of Amper Innovation Factory, who is a well-known and experienced individual in innovation ecosystem, to attend and cooperate, and we are delighted that he has accepted the responsibility of the commercialization and started the necessary actions to form the committee cooperating with experts and the congress scientific secretary Dr. Mowla.
In this meeting, while explaining the goals and plans of this committee, Parviz Karami, the Secretary of Commercialization of the International Cancer genomics congress, stated: Networking and forming cancer prevention and treatment startups in the country's health ecosystem is one of the requirements that can be achieved and introduced to the community as one of the goals of this international scientific and technological event.
He emphasized on identifying and supporting the owners of start-up ideas in cancer prevention and treatment field and announced: investment and commercialization of ideas in this field can lead to the formation of new and efficient businesses for society’s health.
The CEO of Ampere Innovation Factory further considered supporting the creation a cancer start-up ecosystem as one of the effective purposes of the commercialization committee of the Second International Cancer genomics congress and added: removing the existing gaps in the financial support and insurance coverage of cancer patients will be among the achievements that will be gained by The formation of this ecosystem.
Karami added: Unfortunately, the input to the technology and innovation ecosystem, which is also referred as the knowledge-based ecosystem, has become more or less prosperous, and in order to settle down this challenge, it is necessary to support and shape the logical process of the input of the ecosystem in the network of innovation centers and Accelerators and enable the formation of new startups.
For this purpose, helping to hold a commercialization side exhibition consisting knowledge-based companies to introduce commercialization players and benefactors and holding an event named “Idea to Startup” to strengthen the startup ecosystem of Congress (cancer) is one of the goals of this committee.
Kerami also expressed: Therefore, the Ampere Innovation and Creative Industries Factory has entered this field as its social responsibility. As a result, the commercialization unit of the 2nd International Cancer genomics congress will be professionally activated.
The Ampere Life Accelerator as one of the subsectors of the Ampere Innovation Factory also can host numerous startups in the fields of health and wellness, and will try to increase the richness of the startups of this international event.
The secretary of the commercialization committee of the 2nd Cancer genomics congress added: The importance of innovative activities and start-ups to speed up the prevention and treatment of cancer, solutions for early diagnosis of this disease and smart methods for its treatment are among the main concerns of new businesses.
Karami regarding the plans and roadmap of this international congress: Undoubtedly, by promoting innovative solutions in the cancer treatment, the economy and technology of this field will also be strengthened, as a result of which, the quality of society's health will be improved.
Seyed Javad Mowla, the scientific secretary of the 2nd Cancer genomics congress, also mentioned the annual death rate due to cancer in the world and added: 30 to 40 percent of cancer cases and deaths are preventable, and prevention in medical science is considered as the key standard.
The cancer prevention campaign was formed in cooperation with associations and health charity centers in the country, and we hope that by continuing our journey in Cancer genomics congress, we would see an increase in the society health literacy and the institutionalization of a healthy lifestyle in the future.
It also mentionable that the second international Cancer genomics congress (CGC2024) will be held in Tehran,1403, fall in the three categories of science, commercialization and social responsibility.
comments(0)